Weight Loss Study for People Over 40 who are Overweight or Obese and have Cardiovascular Disease
Are you overweight or obese and have previously had a heart attack or stroke, or are living with peripheral artery disease (PAD) or heart failure?
You may be eligible to participate in a clinical research study evaluating an investigational medication called petrelintide for weight management.
ABOUT THE STUDY
This is a Phase 3 clinical research study evaluating how petrelintide affects body weight in adults with overweight or obesity who have established cardiovascular disease, with or without type 2 diabetes.
WHO MAY QUALIFY?
You may be eligible to participate if you meet all the following:
Are over 40 years old
Body mass index (BMI) of 27 or higher (classified as overweight or obesity)
Have a history of cardiovascular disease, such as:
Heart attack
Stroke
Peripheral artery disease (PAD), or
Heart failure
Have not used any GLP-1-based medication — including pills or injections (such as Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, or Foundayo) within the past 6 months
Have never had surgery for treatment of obesity
INTERESTED IN LEARNING MORE?
Click below to complete a short questionnaire to see if you may be eligible.